Women’s Health Innovation Symposium: From Evidence to Investment
Despite rapid advancements in modern medicine, severe clinical data gaps and investment bottlenecks continue to hinder female-centric healthcare. Hosted by Nucleate Switzerland, this premier symposium is designed to break down traditional industry silos by convening a curated ecosystem of venture capitalists, entrepreneurs, clinical operators, and pharmaceutical executives. Together, we will explore actionable strategies to mobilize capital, leverage real-world evidence, and drive systemic change in gender-sensitive medicine.
Join us for an evening of high-impact dialogue featuring some of the most prominent voices in the European healthcare sector. The summit will anchor on a keynote address from Reinhart Capital, followed by two core panels tackling the clinical evidence gap and the frontier of technological venture creation in women's health. Whether you are an investor scaling the next breakthrough, a clinician navigating off-label data, or an entrepreneur building the future of diagnostics, this event offers an unparalleled opportunity to forge the strategic partnerships needed to redefine the standard of care.
This program is proudly sponsored by Blooridge and is supported by Health Science Club.
Agenda
18:30 - 18:35 Nucleate Switzerland Welcome and Introduction
18:35 - 18:50 Keynote: Nina Portier Reinhart, Managing Director & Co-Founder, Reinhart Capital
18:50 - 19:30 Panel One: The Clinical Evidence Gap in Women’s Health
Moderator: Tina Tianlan Cai, Nucleate Switzerland
Leyla Hernandez Donoso: Real-World Evidence (RWE) Expert, Novo Nordisk
Dr. Martin Kiebler: Physician, Obstetrics & Gynecology
Elisabeth Mostofi: Partner, Capys Consulting GmbH | Commercialization Executive with 25+ Years in Global Pharma
Laura Titaro: Co-Founder, Blooridge | Expert in Patient Advocacy and Insurance
19:30 - 19:35 Spotlight Presentation: Nicole Estermann, Managing Director, Artemis Women’s Health Foundation
19:35 - 19:45 Break
19:45 - 20:25 Panel Two: Venture Creation & Technological Innovation in Women’s Health
Moderator: Lan Zuo Gillet, Founder, Tech4Eva
Cinzia Donato: PhD, COO & CSO, Hera Biotech
Lisa Falco: Co-Founder & CEO, N23 Health (Pioneering accessible breast cancer detection) | Forbes Contributor
Alexandra Hirzel: Founder & Investor, The Scale Foundry
Sanjana Rao: Co-Founder, Miyara (AI powered menopause Companion app)
20:25 - 20:30 Special Announcement: New Initiative Introduction
20:30 - 21:30 Networking Apéro